Studies on lung cancer patients have demonstrated that proteins such as CYFRA 21-1, CEA, and NSE can be used to determine the lung cancer subtype or are correlated with the stage and prognosis of the disease. The gene discussed is ENO2; the disease is lung carcinoma.